SV Life Sciences raising sixth fund, goal is $400 million
With nearly $2 billion under management, SV Life Sciences has started raising its sixth fund with a target of $400 million. The group invests in biotechnology, medical devices, health IT, and healthcare services. Click here for more information on the latest effort.
